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guide-wire was passed to original lumen. Next, another guide-wire was passed into
calcified atheroma with intravascular ultrasound guided and dilated the calcified lumen
by balloon angioplasty or rotational atherectomy. Thus, calcified lumen was connected
with original one, the optimal balloon or stent expansion could achieve.
Results: Twenty-eight PAD patients (71.2 ± 10.9 years, 68.9% male) with eccentric
calcification were tried ARCADIA procedure. Fourteen patients had advanced renal
failure on hemodialysis. The lesion was located in the common iliac artery in 8 patients,
common and superficial femoral artery in 20 patients. We failed to pass the wire into
calcification in 4 cases (success rate was 85.7%). Mean follow-up period was 163.5 ±
153.6 days. Ankle brachial index was significantly higher when following up (pre: 0.49
± 0.31 vs. follow-up: 0.74 ± 0.18, p<0.01, 95%CI: 0.13-0.36). Target lesion
revascularization occurred one case (rate was 3.5%). There were no procedural
complication and no in-hospital major adverse cardiovascular events.
Concept of ARCADIA Technique
Conclusion: ARCADIA technique is one of the options to achieve optimal balloon or
stent expansion by dilatation from inside of calcification. It could be effective to PAD
with severe calcification.
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Background: To show efficacy of Cardiatis Multilayer Flow Modulator (CMFM) in
the treatment of peripheral and visceral aneurysms with/without collateral branches
arising from the sac or proximal/distal neck.
Methods: Between june 2009 and june 2010, 54 patients with peripheral (35) and
visceral (19) aneurysms were treated with CMFM in 22 italian clinical centers (16
Interventional Radiology, 3 Vascular Surgery, and 3 Cardiovascular Unit). 40/54
aneurysms had collateral branches arising from the sac or the necks of the lesion. Early
(30 days), midterm (6 months) and late term (12 months) results were analyzed in
terms of technical and clinical success (aneurysm thrombosis, stent and branches
patency); we assessed also the shrinkage/diameter reduction of the sac at 6 and 12
months. All data were recorded in the Italian Registry of Cardiatis Procedures
supported by the Italian Society of Vascular and Interventional Radiology.
Results: Technical success was achieved in all the cases. Clinical success was
evaluated with CT-angiography. We report the data we collected from all the patients
with at least one month FU (49 patients). The 30-days, 6-months and 12-months
clinical success rates (aneurysm thrombosis) were 91,8% (45/49), 95,7% (45/47), and
92,3% (24/26) rispectively, with a 100% rates of side branches patency and stent
patency at the latest FU. While shrinkage at 6 months FU was observed in 70% of
patients, at 12 months FU it was present in 80,8% of cases.
Conclusion: Our experience shows that CMFM appears to be an affective tool in
endovascular exclusion of peripheral and visceral aneurysms with collateral branches,
allowing sac thrombosis and collateral vessels patency with significant
shrinkage/diameter reduction of the sac, allowing a broader group of patients to be
treated with endovascular repair.
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Background: Thoraco Abdominal Aortic Aneurysms(TAA)&Abdominal Aortic
Aneurysms (AAA)are traditionally treated surgically but more and more by
interventional procedures(endografts or fenestrated grafts) with a high technical success
rate,but some problems are not solved like protection of aneurysm
rupture,endoleaks,neurological compl. like paraplegia.We developed a new concept of
stent,the Multilayer stent(MS) to treat these aneurysms and try to avoid some major
complications.
Methods: This MS is a 3D braided tube made of several interconnected layers without
any covering.Our earliest in vitro tests(theorical simulation,computerized Fluid
dynamics,Molecular Modelization)&in vivo tests demonstrate that this MS reduces
the velocity in the aneurismal sac up to90% by modifying the hemodynamic
conditions.A saccular aneurysm without collateral branch will thrombose quickly.If a
collateral branch is present the flow is directed towards this branch leading to shrinkage
of the aneurysm.In fusiform aneurysms the flow is laminated,the vortices
eliminated,reducing the risk of rupture.Animal experiments show excellent
results.Moreover,as demonstrated in animal &human studies this MS preserves the
collateral branches allowing the possibility to cover any artery without compromising
the flow(renal,digestive arteries,supra aortic vessels)
Results: 6 TAA,4 AAA(3 extended to both iliac arteries)in 10 compassionate
cases(˛:9,ˇ:1, mean age 61,4y)were treated with the MS,23 stents(Ø12 to 40 mm,L:8
to 15cm) were implanted by femoral approach. Technical success 100%.No
periprocedural complications.6 to 18 months follow up will be presented.All these
aneurysms were thrombosed with Øreduction in some cases.We will discuss the time
needed to achieve their exclusion. It seems related to the nb and size of the branches
within the aneurysms.All the side branches covered by the MS remained patent
Conclusion: The MS is a new technique which seems promising to treat AAA
&TAAA. It allows to cover any artery without compromising the flow. Larger study is
ongoing.
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Background: Perioperative infection of an aortic graft is one of the most devastating
complications in vascular surgery (mortality is 10-30%). The amputation rate is
generally >25%, depending on anatomic location, graft material, and virulence of the
bacteria. In vitro studies suggest that an antibiotic-impregnated graft could help to
prevent post-graft infection. Generally, staphylococci cause up to 40% of vascular graft
infections. In a pilot study conducted in an animal model, we tested a locally developed
technique of bonding aortic grafts with 2 different antibiotics to evaluate its synergistic
preventative effect on direct perioperative bacterial contamination.
Methods: Vascular Dacron grafts, 6 mm in diameter, were surgically implanted in the
infrarenal portion of the abdominal aorta of 6 Sinclair Miniature swine. Two pigs
received a graft that had been bonded with 60 mg/mL solutions of rifampin and
minocycline; the other 4 pigs received unbonded grafts. Before implantation, the 2
bonded grafts and 2 of the 4 unbonded grafts were immersed in 2 mL of a bacterial
solution containing 1 to 2×107 colony-forming units (CFU)/mL of S. aureus (ATCC
29213) for 15 minutes. Two weeks after graft implantation, the pigs were sacrificed.
Results: Whereas specimens of the 2 S. aureus–treated unbonded grafts had high
bacterial counts (6.25×106 and 1.38×107 CFU/graft), specimens of the 2 S. aureus–
treated bonded grafts showed no bacterial growth. Bacterial growth in the 2 control
pigs’ grafts (1.8×103 and 7.27×103 CFU/graft) reflected direct accidental perioperative
bacterial contamination; the organisms isolated were not S. aureus (S. cohnii spp
urealyticus and S. chromogenes). The histopathologic and clinical data confirmed the
microbiological findings. Only pigs that received unbonded grafts showed
histopathologic evidence of perigraft abscess.
Conclusion: Our results suggest that bonding aortic grafts with 2 antibiotics is a
promising method of reducing direct perioperative bacterial contamination. Further
studies are needed to explore the ability of this novel graft to combat one of the most
feared complications in vascular surgery.
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Relationship between novel angiographic endpoint of endovascular therapy and
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Background: The optimal angiographic endpoint of endovascular therapy (EVT)
remains unclear. The aim of this study was to assess the relationship between the
appearance of wound blush as an angiographic endpoint and the limb salvage rate in
patients with CLI.
Methods: Wound blush was defined as contrast opacification of the vessels around
the wound in digital subtraction angiograms obtained immediately after the EVT
through the catheter introduced into the popliteal artery. We analyzed the data of 77
consecutive patients (93 limbs) with ischemic ulcerations classified as Rutherford
category 5 or 6, who underwent EVT alone. Patients were divided into two groups
depending on whether or not wound blush was obtained in the angiogram obtained
immediately after the procedure, and the ‘freedom from amputation’ rate was compared
between the two groups.
Results: The overall limb salvage rate was 81.7%. The limb salvage rate was
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